Pharmablock convertible bonds face mandatory redemption as conversion window closes

Nanjing Pharmablock Sciences Co. announced that its "Yaoshi Convertible Bonds" will cease conversion on September 17, 2025. Unconverted bonds will be mandatorily redeemed at 100.62 yuan per bond. Investors are urged to convert their bonds before this date to avoid potential investment losses, as the current market price may differ significantly from the redemption price. The company triggered its conditional redemption clause after its stock price exceeded 130% of the current conversion price (43.69 yuan per share) for 15 trading days between July 25 and August 14, 2025.

The mandatory redemption will affect all holders of "Yaoshi Convertible Bonds" registered by the close of business on September 17, 2025. Trading of the bonds will halt on September 15, 2025, with the final conversion day being September 17, 2025. Redemption funds are expected to reach investors' accounts by September 25, 2025. Holders must ensure they have opened a ChiNext trading account to facilitate conversion.

The convertible bond, issued on April 20, 2022, had an initial conversion price of 92.98 yuan per share, which has been adjusted multiple times, most recently to 33.61 yuan per share. This redemption emphasizes the importance of timely action for bondholders to either convert to shares or accept the mandatory redemption.